Last $6.85 USD
Change Today 0.00 / 0.00%
Volume 555.4K
XNPT On Other Exchanges
As of 8:10 PM 02/27/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Ronald W. Barrett Ph.D.

Co-Founder, Chief Executive Officer and Director, Xenoport, Inc.
AgeTotal Calculated CompensationThis person is connected to 19 board members in 2 different organizations across 2 different industries.

See Board Relationships
As of Fiscal Year 2013


Dr. Ronald W. Barrett, Ph.D. co-founded XenoPort, Inc., in 1999 and has been its Chief Executive Officer since September 2001. Dr. Barrett served as the Chief Scientific Officer of Xenoport Inc. from 1999 to 2001. He served as the Senior Vice President of Research at Affymax Research Institute from 1989 to 1999. He served as a Molecular Pharmacologist in Neuroscience Group at Abbott Laboratories from 1986 to 1989. He has industry and board experience, including as chief ...

Read Full Background

Corporate Headquarters*

3410 Central Expressway
Santa Clara, California 95051

United States

Phone: 408-616-7200
Fax: --

Board Members Memberships*

Co-Founder, Chief Executive Officer and Director
Independent Director


Bucknell University
Rutgers, The State University of New Jersey

Other Affiliations*

Annual Compensation*

Total Annual Compensation$500,000

Stock Options*

Restricted Stock Awards$440,000
All Other Compensation$5,874
Exercised Options18,518
Exercised Options Value$93,146
Exercisable Options676,455
Exercisable Options Value$254,002
Unexercisable Options176,877
Unexercisable Options Value$55,079
Total Value of Options$402,227
Total Number of Options871,850

Total Compensation*

Total Annual Cash Compensation$505,874
Total Short Term Compensation$500,000
Other Long Term Compensation$445,874
Total Calculated Compensation$1,670,587
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
XNPT:US $6.85 USD 0.00


Michael S. Anderson Chief Executive Officer and Director
Flamel Technologies SA
Scott Schorer Chief Executive Officer
PlasmaTech Biopharmaceuticals, Inc.
James A. Schoeneck Chief Executive Officer, President and Director
DepoMed Inc.
Mark A. Sirgo Pharm.D.Chief Executive Officer, President, Chief Scientific Officer, Executive Director and Member of Executive Subcommittee
BioDelivery Sciences International, Inc.
Arun Suresh Chandavarkar B.Tech., M.S., Ph.D.(Chemical Eng.)Chief Executive Officer, Joint Managing Director and Additional Director
Biocon Limited
Compensation as of Fiscal Year --.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact XENOPORT INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at